Objectives: The CROSS trial established neoadjuvant chemoradiation followed by surgery (nCRT-S) as superior to surgery alone (S) for locally advanced esophageal cancer (EC). However, because patients above 75 years of age were excluded, this comparison cannot be extrapolated to older patients. This study of a large, contemporary national database evaluated practice patterns in elderly patients ineligible for CROSS, and analyzed overall survival (OS) between nCRT+S, S, and definitive CRT (dCRT). Materials and Methods: The National Cancer Data Base was queried for EC patients with cT1N1M0/T2-3N0-1M0 EC (per the CROSS trial) but 76 years and above of age. Multivariable logistic regression ascertained factors associated with nCRT+S (vs. S). Kaplan-Meier analysis evaluated OS; Cox multivariate analysis determined variables associated with OS. Propensity matching aimed to address group imbalances and indication biases. Results: Of 4099 total patients, 594 (14%) underwent nCRT+S, 494 (12%) underwent S, and 3011 (73%) underwent dCRT. Since 2010, trimodality management has risen, corresponding to declines in S and dCRT. Median OS in the respective groups were 26.7, 20.3, and 17.8 months (P0.05), with lower 30-day readmission and postoperative hospital stay (P
from A via a.sfakia on Inoreader http://bit.ly/2rQ7ev1
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Αρχειοθήκη ιστολογίου
-
►
2023
(272)
- ► Φεβρουαρίου (141)
- ► Ιανουαρίου (131)
-
►
2022
(2066)
- ► Δεκεμβρίου (80)
- ► Σεπτεμβρίου (170)
- ► Φεβρουαρίου (190)
- ► Ιανουαρίου (203)
-
►
2021
(7399)
- ► Δεκεμβρίου (186)
- ► Σεπτεμβρίου (472)
- ► Φεβρουαρίου (851)
-
►
2020
(2517)
- ► Δεκεμβρίου (792)
- ► Σεπτεμβρίου (21)
- ► Φεβρουαρίου (28)
-
►
2019
(12076)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (4765)
- ► Ιανουαρίου (5155)
-
▼
2018
(3144)
-
▼
Δεκεμβρίου
(3144)
-
▼
Δεκ 22
(67)
- Neoadjuvant Interdigitated Chemoradiotherapy Using...
- The University of Florida Department of Radiation ...
- Survival Outcome and Prognostic Factors After Pulm...
- Patterns of Care and Outcomes of Elderly Esophagea...
- Utilization of an Alternative Docetaxel-based Intr...
- Dynamic Angiogenic Switch as Predictor of Response...
- Neoadjuvant Chemotherapy Treatment Modifications i...
- Differential Outcomes Among Immunosuppressed Patie...
- Disparities Predict for Higher Rates of Cut-throug...
- Clinical and Molecular Recursive Partitioning Anal...
- Treatment Patterns and Survival of Elderly Patient...
- Comparison of Outcomes in Patients With Muscle-inv...
- Comparison of Clinical Characteristics and Outcome...
- Safety and Efficacy of Cabozantinib for Metastatic...
- Challenging the Requirement to Treat the Contralat...
- Dose Escalation in Stereotactic Body Radiation The...
- Nuclear Medicine Therapy With 223Radium-dichloride...
- Metabolic relation of cyanobacteria to aromatic co...
- Kinetically selective and potent inhibitors of HDAC8
- An engineered lipocalin that tightly complexes the...
- Directed evolution of the 3C protease from coxsack...
- An Evaluation of Healthcare Use and Child Morbidit...
- Differences in the imaging of Crohn’s disease pati...
- Latanoprostene bunod ophthalmic solution 0.024% in...
- Visuospatial short-term memory and dorsal visual g...
- Atypical neural processing of rise time by adults ...
- Dopamine guides competition for cognitive control:...
- Increased Inhibition Following Negative Cues: A Po...
- Water mobility spectral imaging of the spinal cord...
- SMR Congress 2018 Abstracts
- The 28th Annual Meeting of the Japanese Society fo...
- Issue Information
- The Joint Montagna Symposium on the Biology of Ski...
- BRN2, a POUerful driver of melanoma phenotype swit...
- List of Reviewers for PCMR (01.11.2017–31.10.2018)
- An accessory right hepatic artery derived from the...
- Modification of the existing maximum residue level...
- Modification of the existing maximum residue level...
- Lies Matter
- Tonsillectomy using the BiZact: A pilot study in 1...
- Basophil activation testing in occupational respir...
- A long-wavelength-emitting fluorescent probe for s...
- Screen printed potentiometric sensor for therapeut...
- A Chemiluminescent Probe for HNO Quantification an...
- High Throughput Strategies for the Discovery and O...
- Bidentate Boron‐Lewis Acids – Selectivity in Host‐...
- Reductive Molybdenum‐Catalyzed Direct Amination of...
- Colloidal Synthesis and Charge‐Carrier Dynamics of...
- A Water‐Soluble Perylene Bisimide Cyclophane as a ...
- Remarkable Oxygen‐Evolution Activity of Ca2‐xSrxFe...
- Base‐Mediated Defluorosilylation of sp2 & sp3 C–F ...
- Total Synthesis of (–)‐Merochlorin A
- Stabilizing lithium into cross‐stacked nanotube sh...
- Directed evolution of a designer enzyme featuring ...
- Taming Radical Intermediates for the Construction ...
- Catalytic Atropenantioselective Heteroannulation b...
- Enantiospecific Synthesis of ortho‐Substituted 1,1...
- Assembling a Hybrid Pd Catalyst from a Chiral Anio...
- Orientation of an Amphiphilic Copolymer to a Lamel...
- Active Edge‐Site‐Rich Carbon Nanocatalysts with En...
- Hydrogen‐Bonding‐Regulated Supramolecular Nanostru...
- Copper‐Catalyzed [3+2] Cycloaddition Reactions of ...
- Hydrogenation of Borylated Arenes
- Effect of Audibility and Suprathreshold Deficits o...
- Microbial keratitis: Significant increase in Gram-...
- Giant cell arteritis related arteritic anterior is...
- Ophthalmology
-
▼
Δεκ 22
(67)
-
▼
Δεκεμβρίου
(3144)
Ετικέτες
Πληροφορίες
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Αναζήτηση αυτού του ιστολογίου
! # Ola via Alexandros G.Sfakianakis on Inoreader
-
Publication date: 1 May 2019 Source: Talanta, Volume 196 Author(s): Ruiqing Long, Te Li, Chaoying Tong, Lihui Wu, Shuyun Shi Abstract...
-
Oral Cancer Rapid Test Kit Market Rugged Expansion Foreseen by 2024 MilTech Oral cancer is one of the largest group of cancers ...
-
Related Articles SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,